Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorNew York Medical College
About this trial
The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are:
* To determine the extent to which this combined treatment can improve language. * To determine the extent to which the combined treatment can improve arm movements.
Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female patients between 18-90 years of age.
Right-handed prior to stroke
English-speaking (monolingual)
History of single left-hemisphere stroke at least 6 months prior to enrollment
Disqualifiers
Diagnosis or history of speech impairment prior to stroke
Severely limited speech output (score below 2 on spontaneous speech portion of WAB-R)
Inability to perform screening tasks due to severe language and/or cognitive impairment
Condition limiting passive movement in the range of motion required for robotic therapy (e.g. fixed contracture)
Trial design
Design model
Parallel
Treatments tested in this trial
CARAT: combined aphasia and robot-assisted arm therapy
BehavioralParticipants will receive 18 sessions of robot-assisted arm therapy combined with a standardized picture-word verification therapy task with the goal of improving language and arm movements.
Robot-assisted arm therapy
BehavioralParticipants will receive 18 sessions of robot-assisted arm therapy with the goal of improving arm movements.
Treatment groups
28 Participants
are divided into 2 treatment groupsGroup A: Combined aphasia and robot-assisted arm treatmentExperimental treatment 1 intervention
Group B: Robot-assisted arm treatmentActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Philadelphia Naming Test
Time frame
Baseline to 1 week post-treatment2
Fugl-Meyer Upper Extremity Motor Assessment
Time frame
Baseline to 1 week post-treatmentSecondary outcomes
1
Western Aphasia Battery-Revised Aphasia Quotient
Time frame
Baseline to 4 weeks post-treatment2
Box and Blocks Test
Time frame
Baseline to 1 and 4 weeks post-training3
Apraxia Battery for Adults
Time frame
Baseline to 1 and 4 weeks post-training4
Stroke and Aphasia Quality of Life Scale-39
Time frame
Baseline to 1 and 4 weeks post-trainingOther outcomes
1
Arm kinematics
Time frame
Baseline to 1 and 4 weeks post-training2
Arm vs. Non-Arm Naming
Time frame
Baseline to 1 and 4 weeks post-trainingSponsors and contacts
Click on the lead sponsor to view all of their trials.
New York Medical College
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
New York University
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: